1
|
Deshar G, Christensen NM, Novak I. Pantoprazole and riluzole target H +/K +-ATPases and pH-sensitive K + channels in pancreatic cancer cells. Int J Cancer 2024. [PMID: 38975879 DOI: 10.1002/ijc.35076] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2024] [Revised: 05/28/2024] [Accepted: 06/10/2024] [Indexed: 07/09/2024]
Abstract
Pancreatic ductal adenocarcinoma (PDAC) remains the most lethal cancer type. PDAC is characterized by fibrotic, hypoxic, and presumably acidic tumor microenvironment (TME). Acidic TME is an important player in tumor development, progression, aggressiveness, and chemoresistance. The dysregulation of ductal ion transporters/channels might contribute to extracellular pH (pHe) acidification and PDAC progression. Our aim was to test whether H+/K+-ATPases and pH-sensitive K+ channels contribute to these processes and could be targeted by clinically approved drugs. We used human pancreatic cancer cells adapted to various pHe conditions and grown in monolayers and spheroids. First, we created cells expressing pHoran4 at the outer plasma membrane and showed that pantoprazole, the H+/K+-ATPase inhibitor, alkalinized pHe. Second, we used FluoVolt to monitor the membrane voltage (Vm) and showed that riluzole hyperpolarized Vm, most likely by opening of pH-sensitive K+ channels such as TREK-1. Third, we show that pantoprazole and riluzole inhibited cell proliferation and viability of monolayers and spheroids of cancer cells adapted to various pHe conditions. Most importantly, combination of the two drugs had significantly larger inhibitory effects on PDAC cell survival. We propose that co-targeting H+/K+-ATPases and pH-sensitive K+ channels by re-purposing of pantoprazole and riluzole could provide novel acidosis-targeted therapies of PDAC.
Collapse
Affiliation(s)
- Ganga Deshar
- Department of Biology, University of Copenhagen, Copenhagen, Denmark
| | | | - Ivana Novak
- Department of Biology, University of Copenhagen, Copenhagen, Denmark
| |
Collapse
|
2
|
Pedre B. A guide to genetically-encoded redox biosensors: State of the art and opportunities. Arch Biochem Biophys 2024; 758:110067. [PMID: 38908743 DOI: 10.1016/j.abb.2024.110067] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2024] [Revised: 06/18/2024] [Accepted: 06/19/2024] [Indexed: 06/24/2024]
Abstract
Genetically-encoded redox biosensors have become invaluable tools for monitoring cellular redox processes with high spatiotemporal resolution, coupling the presence of the redox-active analyte with a change in fluorescence signal that can be easily recorded. This review summarizes the available fluorescence recording methods and presents an in-depth classification of the redox biosensors, organized by the analytes they respond to. In addition to the fluorescent protein-based architectures, this review also describes the recent advances on fluorescent, chemigenetic-based redox biosensors and other emerging chemigenetic strategies. This review examines how these biosensors are designed, the biosensors sensing mechanism, and their practical advantages and disadvantages.
Collapse
Affiliation(s)
- Brandán Pedre
- Biochemistry, Molecular and Structural Biology Unit, Department of Chemistry, KU Leuven, Belgium.
| |
Collapse
|
3
|
Belashov AV, Zhikhoreva AA, Salova AV, Belyaeva TN, Litvinov IK, Kornilova ES, Semenova IV, Vasyutinskii OS. Automatic segmentation of lysosomes and analysis of intracellular pH with Radachlorin photosensitizer and FLIM. Biochem Biophys Res Commun 2024; 710:149835. [PMID: 38574457 DOI: 10.1016/j.bbrc.2024.149835] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2024] [Revised: 03/17/2024] [Accepted: 03/25/2024] [Indexed: 04/06/2024]
Abstract
We report application of the fluorescence lifetime imaging microscopy (FLIM) for analysis of distributions of intracellular acidity using a chlorin-e6 based photosensitizer Radachlorin. An almost two-fold increase of the photosensitizer fluorescence lifetime in alkaline microenvironments as compared to acidic ones allowed for clear distinguishing between acidic and alkaline intracellular structures. Clusterization of a phasor plot calculated from fits of the FLIM raw data by two Gaussian distributions provided accurate automatic segmentation of lysosomes featuring acidic contents. The approach was validated in colocalization experiments with LysoTracker fluorescence in living cells of four established lines. The dependence of photosensitizer fluorescence lifetime on microenvironment acidity allowed for estimation of pH inside the cells, except for the nuclei, where photosensitizer does not penetrate. The developed method is promising for combined application of the photosensitizer for both photodynamic treatment and diagnostics.
Collapse
Affiliation(s)
- A V Belashov
- Ioffe Institute, Russian Academy of Sciences, 26, Polytekhnicheskaya, St.Petersburg, 194021, Russia
| | - A A Zhikhoreva
- Ioffe Institute, Russian Academy of Sciences, 26, Polytekhnicheskaya, St.Petersburg, 194021, Russia
| | - A V Salova
- Institute of Cytology, Russian Academy of Sciences, Tikhoretsky Pr., 4, St. Petersburg, 194064, Russia
| | - T N Belyaeva
- Institute of Cytology, Russian Academy of Sciences, Tikhoretsky Pr., 4, St. Petersburg, 194064, Russia
| | - I K Litvinov
- Institute of Cytology, Russian Academy of Sciences, Tikhoretsky Pr., 4, St. Petersburg, 194064, Russia
| | - E S Kornilova
- Institute of Cytology, Russian Academy of Sciences, Tikhoretsky Pr., 4, St. Petersburg, 194064, Russia
| | - I V Semenova
- Ioffe Institute, Russian Academy of Sciences, 26, Polytekhnicheskaya, St.Petersburg, 194021, Russia.
| | - O S Vasyutinskii
- Ioffe Institute, Russian Academy of Sciences, 26, Polytekhnicheskaya, St.Petersburg, 194021, Russia
| |
Collapse
|
4
|
Li SA, Meng XY, Zhang YJ, Chen CL, Jiao YX, Zhu YQ, Liu PP, Sun W. Progress in pH-Sensitive sensors: essential tools for organelle pH detection, spotlighting mitochondrion and diverse applications. Front Pharmacol 2024; 14:1339518. [PMID: 38269286 PMCID: PMC10806205 DOI: 10.3389/fphar.2023.1339518] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2023] [Accepted: 12/20/2023] [Indexed: 01/26/2024] Open
Abstract
pH-sensitive fluorescent proteins have revolutionized the field of cellular imaging and physiology, offering insight into the dynamic pH changes that underlie fundamental cellular processes. This comprehensive review explores the diverse applications and recent advances in the use of pH-sensitive fluorescent proteins. These remarkable tools enable researchers to visualize and monitor pH variations within subcellular compartments, especially mitochondria, shedding light on organelle-specific pH regulation. They play pivotal roles in visualizing exocytosis and endocytosis events in synaptic transmission, monitoring cell death and apoptosis, and understanding drug effects and disease progression. Recent advancements have led to improved photostability, pH specificity, and subcellular targeting, enhancing their utility. Techniques for multiplexed imaging, three-dimensional visualization, and super-resolution microscopy are expanding the horizon of pH-sensitive protein applications. The future holds promise for their integration into optogenetics and drug discovery. With their ever-evolving capabilities, pH-sensitive fluorescent proteins remain indispensable tools for unravelling cellular dynamics and driving breakthroughs in biological research. This review serves as a comprehensive resource for researchers seeking to harness the potential of pH-sensitive fluorescent proteins.
Collapse
Affiliation(s)
- Shu-Ang Li
- Clinical Systems Biology Laboratories, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - Xiao-Yan Meng
- Clinical Systems Biology Laboratories, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- The Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China
| | - Ying-Jie Zhang
- Clinical Systems Biology Laboratories, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- The Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China
| | - Cai-Li Chen
- Department of Immunology, School of Basic Medical Sciences, Xinxiang Medical University, Xinxiang, Henan, China
| | - Yu-Xue Jiao
- Clinical Systems Biology Laboratories, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - Yong-Qing Zhu
- Clinical Systems Biology Laboratories, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
- The Academy of Medical Sciences, Zhengzhou University, Zhengzhou, China
| | - Pei-Pei Liu
- Clinical Systems Biology Laboratories, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - Wei Sun
- Department of Burn and Repair Reconstruction, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| |
Collapse
|
5
|
Mu C, Liu X, Kim Y, Riselli A, Korenchan DE, Bok RA, Delos Santos R, Sriram R, Qin H, Nguyen H, Gordon JW, Slater J, Larson PEZ, Vigneron DB, Kurhanewicz J, Wilson DM, Flavell RR. Clinically Translatable Hyperpolarized 13C Bicarbonate pH Imaging Method for Use in Prostate Cancer. ACS Sens 2023; 8:4042-4054. [PMID: 37878761 PMCID: PMC10683509 DOI: 10.1021/acssensors.3c00851] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2023] [Revised: 09/20/2023] [Accepted: 09/25/2023] [Indexed: 10/27/2023]
Abstract
Solid tumors such as prostate cancer (PCa) commonly develop an acidic microenvironment with pH 6.5-7.2, owing to heterogeneous perfusion, high metabolic activity, and rapid cell proliferation. In preclinical prostate cancer models, disease progression is associated with a decrease in tumor extracellular pH, suggesting that pH imaging may reflect an imaging biomarker to detect aggressive and high-risk disease. Therefore, we developed a hyperpolarized carbon-13 MRI method to image the tumor extracellular pH (pHe) and prepared it for clinical translation for detection and risk stratification of PCa. This method relies on the rapid breakdown of hyperpolarized (HP) 1,2-glycerol carbonate (carbonyl-13C) via base-catalyzed hydrolysis to produce HP 13CO32-, which is neutralized and converted to HP H13CO3-. After injection, HP H13CO3- equilibrates with HP 13CO2 in vivo and enables the imaging of pHe. Using insights gleaned from mechanistic studies performed in the hyperpolarized state, we solved issues of polarization loss during preparation in a clinical polarizer system. We successfully customized a reaction apparatus suitable for clinical application, developed clinical standard operating procedures, and validated the radiofrequency pulse sequence and imaging data acquisition with a wide range of animal models. The results demonstrated that we can routinely produce a highly polarized and safe HP H13CO3- contrast agent suitable for human injection. Preclinical imaging studies validated the reliability and accuracy of measuring acidification in healthy kidney and prostate tumor tissue. These methods were used to support an Investigational New Drug application to the U.S. Food and Drug Administration. This methodology is now ready to be implemented in human trials, with the ultimate goal of improving the management of PCa.
Collapse
Affiliation(s)
- Changhua Mu
- Department
of Radiology and Biomedical Imaging, University
of California, San Francisco, San Francisco, California 94107, United States
| | - Xiaoxi Liu
- Department
of Radiology and Biomedical Imaging, University
of California, San Francisco, San Francisco, California 94107, United States
| | - Yaewon Kim
- Department
of Radiology and Biomedical Imaging, University
of California, San Francisco, San Francisco, California 94107, United States
| | - Andrew Riselli
- Department
of Radiology and Biomedical Imaging, University
of California, San Francisco, San Francisco, California 94107, United States
| | - David E. Korenchan
- Department
of Radiology and Biomedical Imaging, University
of California, San Francisco, San Francisco, California 94107, United States
| | - Robert A. Bok
- Department
of Radiology and Biomedical Imaging, University
of California, San Francisco, San Francisco, California 94107, United States
| | - Romelyn Delos Santos
- Department
of Radiology and Biomedical Imaging, University
of California, San Francisco, San Francisco, California 94107, United States
| | - Renuka Sriram
- Department
of Radiology and Biomedical Imaging, University
of California, San Francisco, San Francisco, California 94107, United States
| | - Hecong Qin
- Department
of Radiology and Biomedical Imaging, University
of California, San Francisco, San Francisco, California 94107, United States
| | - Hao Nguyen
- Department
of Urology, University of California, San Francisco, California 94143, United States
| | - Jeremy W. Gordon
- Department
of Radiology and Biomedical Imaging, University
of California, San Francisco, San Francisco, California 94107, United States
| | - James Slater
- Department
of Radiology and Biomedical Imaging, University
of California, San Francisco, San Francisco, California 94107, United States
| | - Peder E. Z. Larson
- Department
of Radiology and Biomedical Imaging, University
of California, San Francisco, San Francisco, California 94107, United States
| | - Daniel B. Vigneron
- Department
of Radiology and Biomedical Imaging, University
of California, San Francisco, San Francisco, California 94107, United States
| | - John Kurhanewicz
- Department
of Radiology and Biomedical Imaging, University
of California, San Francisco, San Francisco, California 94107, United States
| | - David M. Wilson
- Department
of Radiology and Biomedical Imaging, University
of California, San Francisco, San Francisco, California 94107, United States
| | - Robert R. Flavell
- Department
of Radiology and Biomedical Imaging, University
of California, San Francisco, San Francisco, California 94107, United States
- Department
of Pharmaceutical Chemistry, University
of California, San Francisco, California 94158, United States
| |
Collapse
|
6
|
Vu CQ, Arai S. Quantitative Imaging of Genetically Encoded Fluorescence Lifetime Biosensors. BIOSENSORS 2023; 13:939. [PMID: 37887132 PMCID: PMC10605767 DOI: 10.3390/bios13100939] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/05/2023] [Revised: 10/16/2023] [Accepted: 10/17/2023] [Indexed: 10/28/2023]
Abstract
Genetically encoded fluorescence lifetime biosensors have emerged as powerful tools for quantitative imaging, enabling precise measurement of cellular metabolites, molecular interactions, and dynamic cellular processes. This review provides an overview of the principles, applications, and advancements in quantitative imaging with genetically encoded fluorescence lifetime biosensors using fluorescence lifetime imaging microscopy (go-FLIM). We highlighted the distinct advantages of fluorescence lifetime-based measurements, including independence from expression levels, excitation power, and focus drift, resulting in robust and reliable measurements compared to intensity-based approaches. Specifically, we focus on two types of go-FLIM, namely Förster resonance energy transfer (FRET)-FLIM and single-fluorescent protein (FP)-based FLIM biosensors, and discuss their unique characteristics and benefits. This review serves as a valuable resource for researchers interested in leveraging fluorescence lifetime imaging to study molecular interactions and cellular metabolism with high precision and accuracy.
Collapse
Affiliation(s)
- Cong Quang Vu
- WPI Nano Life Science Institute, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, Japan
| | - Satoshi Arai
- WPI Nano Life Science Institute, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, Japan
| |
Collapse
|
7
|
Mo Y, Zhou H, Xu J, Chen X, Li L, Zhang S. Genetically encoded fluorescence lifetime biosensors: overview, advances, and opportunities. Analyst 2023; 148:4939-4953. [PMID: 37721109 DOI: 10.1039/d3an01201h] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/19/2023]
Abstract
Genetically encoded biosensors based on fluorescent proteins (FPs) are powerful tools for tracking analytes and cellular events with high spatial and temporal resolution in living cells and organisms. Compared with intensiometric readout and ratiometric readout, fluorescence lifetime readout provides absolute measurements, independent of the biosensor expression level and instruments. Thus, genetically encoded fluorescence lifetime biosensors play a vital role in facilitating accurate quantitative assessments within intricate biological systems. In this review, we first provide a concise description of the categorization and working mechanism of genetically encoded fluorescence lifetime biosensors. Subsequently, we elaborate on the combination of the fluorescence lifetime imaging technique and lifetime analysis methods with fluorescence lifetime biosensors, followed by their application in monitoring the dynamics of environment parameters, analytes and cellular events. Finally, we discuss worthwhile considerations for the design, optimization and development of fluorescence lifetime-based biosensors from three representative cases.
Collapse
Affiliation(s)
- Yidan Mo
- State Key Laboratory of Precision Spectroscopy, East China Normal University, No. 500, Dongchuan Rd, Shanghai 200241, China
| | - Huangmei Zhou
- State Key Laboratory of Precision Spectroscopy, East China Normal University, No. 500, Dongchuan Rd, Shanghai 200241, China
| | - Jinming Xu
- State Key Laboratory of Precision Spectroscopy, East China Normal University, No. 500, Dongchuan Rd, Shanghai 200241, China
| | - Xihang Chen
- State Key Laboratory of Precision Spectroscopy, East China Normal University, No. 500, Dongchuan Rd, Shanghai 200241, China
| | - Lei Li
- School of Science, Jiangnan University, 1800 Lihu Avenue, Wuxi, Jiangsu, 214122, China.
| | - Sanjun Zhang
- State Key Laboratory of Precision Spectroscopy, East China Normal University, No. 500, Dongchuan Rd, Shanghai 200241, China
- Collaborative Innovation Center of Extreme Optics, Shanxi University, Taiyuan, Shanxi 030006, China
- NYU-ECNU Institute of Physics at NYU Shanghai, No. 3663, North Zhongshan Rd, Shanghai 200062, China.
| |
Collapse
|
8
|
Kimura Y, Inagawa A, Uehara N. Rapid acquisition of absorption spectra to monitor proton migration in nanoliter space using the RGB-spectrum-conversion method with a 10 ms interval. ANAL SCI 2023:10.1007/s44211-023-00348-y. [PMID: 37097514 DOI: 10.1007/s44211-023-00348-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2023] [Accepted: 04/13/2023] [Indexed: 04/26/2023]
Abstract
Acquisition protocol of absorption spectra at nanoliter spaces from the RGB values preserved in video data at 10 ms intervals was established using the principal-component-analysis-based RGB-conversion method. Proton behavior was monitored using a camera to acquire the video footage to monitor colorimetric change in the nanoliter space. The RGB values observed in the video were converted into a score vector using a conversion matrix. A linear combination of the predetermined loading vectors with the score values was calculated to reproduce the absorption spectra. The reproduced absorption spectra correlated well with those acquired using a conventional spectrophotometer during a short period. This method was applied to monitor the proton diffusion from a single cationic ion-exchange resin into hydrogels at low concentrations. The rapid acquisition and quick response of this method may enable the monitoring of the initial diffusion of protons, which is challenging with conventional spectrophotometry and electrochemical approaches.
Collapse
Affiliation(s)
- Yusuke Kimura
- Faculty of Engineering, Utsunomiya University, 7-1-2, Yoto, Utsunomiya,, Tochigi, 321-8585, Japan
| | - Arinori Inagawa
- Faculty of Engineering, Utsunomiya University, 7-1-2, Yoto, Utsunomiya,, Tochigi, 321-8585, Japan.
| | - Nobuo Uehara
- Faculty of Engineering, Utsunomiya University, 7-1-2, Yoto, Utsunomiya,, Tochigi, 321-8585, Japan
| |
Collapse
|
9
|
Druzhkova I, Nikonova E, Ignatova N, Koryakina I, Zyuzin M, Mozherov A, Kozlov D, Krylov D, Kuznetsova D, Lisitsa U, Shcheslavskiy V, Shirshin EA, Zagaynova E, Shirmanova M. Effect of Collagen Matrix on Doxorubicin Distribution and Cancer Cells' Response to Treatment in 3D Tumor Model. Cancers (Basel) 2022; 14:cancers14225487. [PMID: 36428580 PMCID: PMC9688511 DOI: 10.3390/cancers14225487] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2022] [Revised: 11/05/2022] [Accepted: 11/07/2022] [Indexed: 11/11/2022] Open
Abstract
The extracellular matrix (ECM) plays an important role in regulation of many aspects of tumor growth and response to therapies. However, the specifics of the interaction of chemotherapeutic agents with cancer cells in the presence of collagen, the major component of ECM, is still poorly investigated. In this study, we explored distribution of doxorubicin (DOX) and its effects on cancer cells' metabolism in the presence of collagen with different structures in 3D models. For this, a combination of second harmonic generation imaging of collagen and multiphoton fluorescence microscopy of DOX, and metabolic cofactor NAD(P)H was used. It was found that collagen slowed down the diffusion of DOX and thus decreased the cellular drug uptake. Besides nuclei, DOX also targeted mitochondria leading to inhibition of oxidative phosphorylation, which was more pronounced in the cells growing in the absence of collagen. As a result, the cells in collagen displayed better viability upon treatment with DOX. Taken together, our data illustrate that tumor collagen contributes to heterogeneous and sub-optimal response to DOX and highlight the challenges in improving drug delivery and efficacy.
Collapse
Affiliation(s)
- Irina Druzhkova
- Research Institute of Experimental Oncology and Biotechnology, Privolzhsky Research Medical University, 603005 Nizhny Novgorod, Russia
- Correspondence:
| | - Elena Nikonova
- Lomonosov Moscow State University, 119991 Moscow, Russia
- Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 119991 Moscow, Russia
| | - Nadezhda Ignatova
- Research Institute of Experimental Oncology and Biotechnology, Privolzhsky Research Medical University, 603005 Nizhny Novgorod, Russia
| | - Irina Koryakina
- School of Physics and Engineering, ITMO University, 9 Lomonosova St., 191002 St. Petersburg, Russia
| | - Mikhail Zyuzin
- School of Physics and Engineering, ITMO University, 9 Lomonosova St., 191002 St. Petersburg, Russia
| | - Artem Mozherov
- Research Institute of Experimental Oncology and Biotechnology, Privolzhsky Research Medical University, 603005 Nizhny Novgorod, Russia
| | - Dmitriy Kozlov
- Research Institute of Experimental Oncology and Biotechnology, Privolzhsky Research Medical University, 603005 Nizhny Novgorod, Russia
| | - Dmitry Krylov
- Research Institute of Experimental Oncology and Biotechnology, Privolzhsky Research Medical University, 603005 Nizhny Novgorod, Russia
| | - Daria Kuznetsova
- Research Institute of Experimental Oncology and Biotechnology, Privolzhsky Research Medical University, 603005 Nizhny Novgorod, Russia
- Lobachevsky State University of Nizhny Novgorod, 603022 Nizhny Novgorod, Russia
| | - Uliyana Lisitsa
- Research Institute of Experimental Oncology and Biotechnology, Privolzhsky Research Medical University, 603005 Nizhny Novgorod, Russia
| | - Vladislav Shcheslavskiy
- Research Institute of Experimental Oncology and Biotechnology, Privolzhsky Research Medical University, 603005 Nizhny Novgorod, Russia
| | - Evgeny A. Shirshin
- Lomonosov Moscow State University, 119991 Moscow, Russia
- Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 119991 Moscow, Russia
| | - Elena Zagaynova
- Research Institute of Experimental Oncology and Biotechnology, Privolzhsky Research Medical University, 603005 Nizhny Novgorod, Russia
- Lobachevsky State University of Nizhny Novgorod, 603022 Nizhny Novgorod, Russia
| | - Marina Shirmanova
- Research Institute of Experimental Oncology and Biotechnology, Privolzhsky Research Medical University, 603005 Nizhny Novgorod, Russia
| |
Collapse
|
10
|
Druzhkova I, Nikonova E, Ignatova N, Koryakina I, Zyuzin M, Mozherov A, Kozlov D, Krylov D, Kuznetsova D, Lisitsa U, Shcheslavskiy V, Shirshin EA, Zagaynova E, Shirmanova M. Effect of Collagen Matrix on Doxorubicin Distribution and Cancer Cells’ Response to Treatment in 3D Tumor Model. Cancers (Basel) 2022; 14:5487. [DOI: https:/doi.org/10.3390/cancers14225487] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/30/2023] Open
Abstract
The extracellular matrix (ECM) plays an important role in regulation of many aspects of tumor growth and response to therapies. However, the specifics of the interaction of chemotherapeutic agents with cancer cells in the presence of collagen, the major component of ECM, is still poorly investigated. In this study, we explored distribution of doxorubicin (DOX) and its effects on cancer cells’ metabolism in the presence of collagen with different structures in 3D models. For this, a combination of second harmonic generation imaging of collagen and multiphoton fluorescence microscopy of DOX, and metabolic cofactor NAD(P)H was used. It was found that collagen slowed down the diffusion of DOX and thus decreased the cellular drug uptake. Besides nuclei, DOX also targeted mitochondria leading to inhibition of oxidative phosphorylation, which was more pronounced in the cells growing in the absence of collagen. As a result, the cells in collagen displayed better viability upon treatment with DOX. Taken together, our data illustrate that tumor collagen contributes to heterogeneous and sub-optimal response to DOX and highlight the challenges in improving drug delivery and efficacy.
Collapse
|